e-learning
resources
London 2016
Tuesday, 06.09.2016
Screening, diagnosis, assessment, and treatment of COPD in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Medical and demographic loss of population due to chronic obstructive pulmonary disease
Fedor Malykhin (Stavropol, Russian Federation), Fedor Malykhin, Alesya Khripunova
Source:
International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Session:
Screening, diagnosis, assessment, and treatment of COPD in primary care
Session type:
Thematic Poster
Number:
3929
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Fedor Malykhin (Stavropol, Russian Federation), Fedor Malykhin, Alesya Khripunova. Medical and demographic loss of population due to chronic obstructive pulmonary disease. Eur Respir J 2016; 48: Suppl. 60, 3929
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Related content which might interest you:
Clinical features of chronic obstructive pulmonary disease in never smokers
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Characteristics and consequences of chronic obstructive pulmonary disease in never smokers
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Predictors of exacerbation frequency in chronic obstructive pulmonary disease
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Clinical characteristics and health burden of patients with chronic obstructive pulmonary disease exacerbation
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015
Chronic obstructive pulmonary disease and sudden cardiac death: The Rotterdam study
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
Predictive accuracy of a simple functional index in chronic obstructive pulmonary disease
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Current maintenance treatment of chronic obstructive pulmonary disease in China
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Effects of pulmonary rehabilitation on exacerbation number and severity in people with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014
Comparison of gender-related risk factors for COPD – Results from the Canadian obstructive lung disease (CanCOLD) study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Relation of American Heart Association’s life’s simple 7 cardiovascular health factors with chronic obstructive pulmonary disease
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Healthcare utilization and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Chronic obstructive pulmonary disease and comorbidities
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Chronic obstructive pulmonary disease phenotypes, nutritional status and the risk of falls
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016
Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014
Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016
Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Nutritional status in chronic obstructive pulmonary disease
Source: International Congress 2014 – Comorbidities
Year: 2014
Dietary habits in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept